Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B12 and saffron to prevent oxaliplatin-induced neurotoxicity in colorectal and gastric cancer
IRCT20200408046990N10Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cyanocobalamin and saffron in colorectal cancer (CRC), gastric cancer (GC) and peripheral neuropathy (CIPN), sponsored by Mashhad University of Medical Sciences. Started Sep 2022; status: completed.
02
Drugs
cyanocobalaminsaffron
03
Conditions
colorectal cancer (CRC)gastric cancer (GC)peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on IRCT20200408046990N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200408046990N10.